UPDATE: Raymond James Downgrades NexImmune Inc (NEXI) to Market Perform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. SPY
7. CVS
8. UNH
9. DAL
10. TMUS

Go back to UPDATE: Raymond James Downgrades NexImmune Inc (NEXI) to Market Perform

NexImmune Reports Third Quarter 2022 Financial Results and Announces Strategic Update

November 14, 2022 4:01 PM EST

Company announces a strategic shift to focus on advancing its AIM Direct Injection (AIM INJ) platform and potential product candidates in oncology and autoimmune diseasesInitiating a corporate resource reallocation to advance the AIM INJ platform, reduce operating expenses and extend cash runway through the third quarter of 2023 Pausing enrollment and initiation for the NEXI-001 and NEXI-003 trials, respectively, and pursuing external clinical development through potential academic and corporate partners

GAITHERSBURG, Md., Nov. 14, 2022... More